Testing effectiveness (Phase 2)Study completedNCT01252628
What this trial is testing
Phase 1 and 2 Study of PX-866 and Cetuximab
Who this might be right for
Incurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cascadian Therapeutics Inc. 178